The AACR-CRUK Transatlantic Fellowships support promising postdoctoral cancer researchers at US and UK research institutions to carry out a portion of their postdoctoral research at a research institution in the UK or the US, respectively. The AACR-CRUK fellows share the impact of this unique program on their careers and research.
The 2020 AACR-The Mark Foundation for Cancer Research “Science of the Patient” SOP Grants Program seeks to stimulate novel research on the interplay between patient physiology and the tumor. The five grantees have been conducting breakthrough research -- studying cancer not as an isolated phenomenon but as a systemic disease.
The AACR and Bayer have been collaborating since 2015 to support the most promising and innovative cancer-focused research through different grant mechanisms. This partnership has yielded significant fruits, as indicated in this article.
The American Association for Cancer Research (AACR) is proud to announce a new collaboration with a grants program aimed at reducing the burden of cancer in Africa. In 2010, the U.S. National Cancer Institute (NCI) Center for Global Health (CGH), in partnership...
October is breast cancer awareness month. Researchers supported by the partnership between the AACR and the Breast Cancer Research Foundation have made progress in the understanding and treatment of breast cancer on multiple fronts.
October is breast cancer awareness month. Researchers supported by the partnership between the AACR and the Triple-Negative Breast Cancer Foundation have made progress against triple-negative breast cancer on multiple fronts.
In recognition of the need to advance the science of lung cancer prevention and interception, the 2019 AACR-J&J Lung Cancer Innovation Science Grants program awarded grants to two multi-institutional teams whose multifaceted projects seek to understand how an individual’s genetics may affect smoking-related behaviors and quit attempts, as well as to develop clinically actionable smoking cessation strategies that will improve patient outcomes.
The partnership of the AACR with QuadW reflects the commitment of both organizations to make a difference in the lives of sarcoma patients by supporting the next generation of cancer researchers who are focused on sarcoma research.
The AACR-Bristol Myers Squibb Midcareer Female Investigator Grant is the AACR’s first dedicated funding mechanism for midcareer scientists, as well as the first dedicated for women. The goal is to ensure that midcareer female researchers have the resources they need to successfully establish themselves as independent investigators with productive research labs.
Grantees Sahand Hormoz, PhD, and Robert Eil, MD, show the potential of out-of-the-box thinking as they pursue projects that take on major challenges in cancer research with the hope of transforming future clinical practice.